Integrating heart imaging and proteomics identifies drug targets for cardiovascular diseases

Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality, with significant residual risk unexplained by traditional factors. The discovery of novel therapeutic targets or the repurposing of existing drug targets could improve the prevention and treatment for different CVDs. However, previous studies have encountered different analytic challenges, such as failing to cover the whole spectrum of CVDs,

from Breaking World Pharma News https://ift.tt/7ndYgCI